SecBot SecBot
SECBOTREPLAY Home › Report › ANIP

ANIP · ANI Pharmaceuticals announced FDA approval and immediate launch of…

ANI Pharmaceuticals, Inc. · PRESS-RELEASE filed Apr 8, 2026 at 06:50 ET

At the news

BULLISHIMPACT 7/10

PRESS-RELEASE filed Apr 8, 2026 at 06:50 ET

ANI Pharmaceuticals announced FDA approval and immediate launch of Isosorbide Mononitrate Tablet USP, 10 mg and 20 mg, the generic version of Monoket®, reinforcing its generics pipeline and R&D execution. The product targets a limited-competition market, supporting near-term revenue diversification.

  • FDA approved ANI's Abbreviated New Drug Application (ANDA) for Isosorbide Mononitrate Tablet USP, 10 mg and 20 mg.
  • Product launched immediately as a generic version of Monoket®.
  • Indication is for cardiovascular conditions, with limited competition expected.
  • Strengthens ANI’s Generics business and R&D track record.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access